These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 27036918)

  • 1. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC
    J Am Coll Cardiol; 2016 Sep; 68(10):1082-115. PubMed ID: 27036918
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC; Halperin JL; Levine GN; Al-Khatib SM; Birtcher KK; Bozkurt B; Brindis RG; Cigarroa JE; Curtis LH; Fleisher LA; Gentile F; Gidding S; Hlatky MA; Ikonomidis JS; Joglar JA; Pressler SJ; Wijeysundera DN
    J Thorac Cardiovasc Surg; 2016 Nov; 152(5):1243-1275. PubMed ID: 27751237
    [No Abstract]   [Full Text] [Related]  

  • 4. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
    Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC
    Circulation; 2016 Sep; 134(10):e123-55. PubMed ID: 27026020
    [No Abstract]   [Full Text] [Related]  

  • 5. Perioperative management of dual anti-platelet therapy.
    Webster TD; Vaishnava P; Eagle KA
    Hosp Pract (1995); 2016 Dec; 44(5):237-241. PubMed ID: 27846735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.
    Paravattil B; Elewa H
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):347-355. PubMed ID: 28587584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison.
    Capodanno D; Alfonso F; Levine GN; Valgimigli M; Angiolillo DJ
    J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2915-2931. PubMed ID: 30522654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction to: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guidelineon Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
    Circulation; 2016 Sep; 134(10):e192-4. PubMed ID: 27601566
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.
    Camaro C; Damen SA; Brouwer MA; Kedhi E; Lee SW; Verdoia M; Barbieri L; Rognoni A; van T Hof AW; Ligtenberg E; de Boer MJ; Suryapranata H; De Luca G
    Am Heart J; 2016 Aug; 178():37-44. PubMed ID: 27502850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.
    Pandit A; Giri S; Hakim FA; Fortuin FD
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):34-40. PubMed ID: 24753084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current developments in dual antiplatelet therapy after stenting.
    Giacoppo D; Baber U; Mehran R
    Minerva Cardioangiol; 2014 Jun; 62(3):261-76. PubMed ID: 24831762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    ;
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):E1-40. PubMed ID: 18080332
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral dual antiplatelet therapy: what have we learnt from recent trials?
    Montalescot G; Sabatine MS
    Eur Heart J; 2016 Jan; 37(4):344-52. PubMed ID: 26248569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Antiplatelet Therapy Beyond One Year in Patients After Stent Placement: A Review.
    Sumner JD; Zinser B; Smith A
    J Pharm Pract; 2018 Jun; 31(3):335-341. PubMed ID: 28629303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should all stent patients have prolonged dual antiplatelet therapy?
    Kirtane AJ; King SB
    JACC Cardiovasc Interv; 2015 May; 8(6):873-875. PubMed ID: 25999115
    [No Abstract]   [Full Text] [Related]  

  • 16. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).
    Valgimigli M; Bueno H; Byrne RA; Collet JP; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann FJ; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL; Levine GN; ; ;
    Eur Heart J; 2018 Jan; 39(3):213-260. PubMed ID: 28886622
    [No Abstract]   [Full Text] [Related]  

  • 17. Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients.
    Sabouret P; Savage MP; Fischman D; Costa F
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):21-34. PubMed ID: 32394296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    Kushner FG; Hand M; Smith SC; King SB; Anderson JL; Antman EM; Bailey SR; Bates ER; Blankenship JC; Casey DE; Green LA; Jacobs AK; Hochman JS; Krumholz HM; Morrison DA; Ornato JP; Pearle DL; Peterson ED; Sloan MA; Whitlow PL; Williams DO; ;
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):E25-68. PubMed ID: 19924773
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
    Parker WA; Storey RF
    Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction to: Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation; 2016 Sep; 134(10):e195-7. PubMed ID: 27601567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 44.